Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Mark E Saad

Director at Axsome Therapeutics, Inc. (AXSM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.2M

Reported trades

Filed Stock Type Shares Price Value Since
Jan 2SEC AXSMAxsome Therapeutics, Inc. Sell Plan 6,23110,002 held (−38%) $165.18 $1.0M -4.9%
Jan 2SEC AXSMAxsome Therapeutics, Inc. Sell Plan 31,34610,002 held (−76%) $165.18 $5.2M -4.9%
  • Sell

    Director Mark E Saad sold $1.0M of AXSM at $165.18 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Mark E Saad sold $5.2M of AXSM at $165.18 — cuts the stake by 76%; pre-scheduled 10b5-1 plan sale.